Gal Noyman-Veksler


Current Summit Page

Gal is an investment principal at LionBird, a seed stage digital health fund. Gal previously co-founded and served as CEO of NeuroLabs AI, an opioids dependence prevention platform, tackling the opioid epidemic through ongoing assessment of pain and mood symptoms at home. Gal also previously served as VP Business Development and Director of Healthcare at a multinational AI expert firm, and as an investment analyst at aMoon, the largest venture capital fund in Israel.
Gal holds a PhD in Clinical and NeuroPsychology in chronic pain (for which she was awarded the national Wolf Scholarship) and has frequently published in top tier medical journals such as Vaccine and Psychiatry.

Gal is attending / has attended:

VSVC West 2021
Venture Summit Virtual Connect | Global 21
Venture Summit Virtual Connect 21

Join over 300k Investors And Innovators

Sign up now to stay up-to-date with all our events, news, deals and more!